MorphoSys AG (MOR)
17.89
+0.38
(+2.17%)
USD |
NASDAQ |
May 02, 16:00
17.89
0.00 (0.00%)
After-Hours: 18:38
MorphoSys Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | -664.57M |
| March 31, 2022 | -680.13M |
| December 31, 2021 | -569.64M |
| September 30, 2021 | -463.83M |
| June 30, 2021 | -283.24M |
| March 31, 2021 | -242.30M |
| December 31, 2020 | 40.28M |
| September 30, 2020 | 75.45M |
| June 30, 2020 | 123.91M |
| March 31, 2020 | 167.38M |
| December 31, 2019 | -90.76M |
| September 30, 2019 | -72.67M |
| June 30, 2019 | -42.29M |
| March 31, 2019 | -33.43M |
| December 31, 2018 | -38.71M |
| September 30, 2018 | -14.54M |
| June 30, 2018 | -57.88M |
| March 31, 2018 | -65.67M |
| December 31, 2017 | -43.54M |
| September 30, 2017 | -59.44M |
| June 30, 2017 | -65.22M |
| March 31, 2017 | -51.50M |
| December 31, 2016 | -51.59M |
| September 30, 2016 | -53.15M |
| June 30, 2016 | -45.53M |
| Date | Value |
|---|---|
| March 31, 2016 | -38.78M |
| December 31, 2015 | -26.09M |
| September 30, 2015 | -18.73M |
| June 30, 2015 | -4.115M |
| March 31, 2015 | -5.289M |
| December 31, 2014 | -18.91M |
| September 30, 2014 | -19.56M |
| June 30, 2014 | 104.60M |
| March 31, 2014 | 100.15M |
| December 31, 2013 | 118.38M |
| September 30, 2013 | 132.81M |
| June 30, 2013 | 4.104M |
| March 31, 2013 | 6.953M |
| December 31, 2012 | 2.301M |
| September 30, 2012 | -10.18M |
| June 30, 2012 | -10.52M |
| March 31, 2012 | 25.03M |
| December 31, 2011 | 37.74M |
| September 30, 2011 | 43.12M |
| June 30, 2011 | 12.88M |
| March 31, 2011 | 0.1099M |
| December 31, 2010 | 2.507M |
| September 30, 2010 | 4.781M |
| June 30, 2010 | 25.94M |
| March 31, 2010 | 18.89M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-680.13M
Minimum
Mar 2022
167.38M
Maximum
Mar 2020
-207.88M
Average
-90.76M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| Incyte Corp | 820.90M |
| Novartis AG | 13.77B |
| Immatics NV | 19.73M |
| Affimed NV | -119.38M |
| InflaRx NV | -40.94M |